Clinical Trials Directory

Trials / Completed

CompletedNCT00711139

Long-term Safety and Tolerability of AFFITOPE AD01

Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Affiris AG · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the long-term tolerability and -safety of AFFITOPE AD01 applied during AFFiRiS 001

Conditions

Timeline

Start date
2008-06-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2008-07-08
Last updated
2010-05-27

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00711139. Inclusion in this directory is not an endorsement.

Long-term Safety and Tolerability of AFFITOPE AD01 (NCT00711139) · Clinical Trials Directory